GB2001995A

GB2001995A – An immunostimulant, a process for preparing it, and compositions containing it
– Google Patents

GB2001995A – An immunostimulant, a process for preparing it, and compositions containing it
– Google Patents
An immunostimulant, a process for preparing it, and compositions containing it

Info

Publication number
GB2001995A

GB2001995A
GB7831772A
GB7831772A
GB2001995A
GB 2001995 A
GB2001995 A
GB 2001995A
GB 7831772 A
GB7831772 A
GB 7831772A
GB 7831772 A
GB7831772 A
GB 7831772A
GB 2001995 A
GB2001995 A
GB 2001995A
Authority
GB
United Kingdom
Prior art keywords
immunostimulant
water
substance
soluble
alpha
Prior art date
1977-08-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Withdrawn

Application number
GB7831772A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bpifrance Financement SA

Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1977-08-04
Filing date
1978-07-31
Publication date
1979-02-14

1978-07-31
Application filed by Agence National de Valorisation de la Recherche ANVAR
filed
Critical
Agence National de Valorisation de la Recherche ANVAR

1979-02-14
Publication of GB2001995A
publication
Critical
patent/GB2001995A/en

Status
Withdrawn
legal-status
Critical
Current

Links

Espacenet

Global Dossier

Discuss

Classifications

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE

C12P21/00—Preparation of peptides or proteins

C12P21/005—Glycopeptides, glycoproteins

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution

A61K35/66—Microorganisms or materials therefrom

A61K35/74—Bacteria

A—HUMAN NECESSITIES

A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE

A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P31/12—Antivirals

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA

C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor

C12N1/20—Bacteria; Culture media therefor

C12N1/205—Bacterial isolates

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE

C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 – C12P39/00, by using microorganisms or enzymes

C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 – C12P39/00, by using microorganisms or enzymes by using actinomycetales

C—CHEMISTRY; METALLURGY

C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING

C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C – C12Q, RELATING TO MICROORGANISMS

C12R2001/00—Microorganisms ; Processes using microorganisms

C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

C12R2001/465—Streptomyces

Abstract

An immunostimulant substance, denoted 34129 RP, is obtained from delipidated cells of Streptomyces stimulosus DS 25556 (NRRL 5776), by a process which comprises subjecting these delipidated cells to repeated autolysis, thereafter fractionating the water-soluble portion of the autolysis product by ultrafiltration to obtain substances whose molecular weight is 2000 to 20,000, and isolating the water- soluble substance 34129RP thus obtained after lyophilization of the solution. The immunostimulant substance is water-soluble, and can be administered by numerous routes to humans and to animals, preferably in the form of conventional pharmaceutical formulations. The immunostimulant, which has an elementary analysis; C40.4-41.1%; H 6.7-6.9%, N 8.0-10.6%, comprises alamine (5 to 7%), glutamic acid (7 to 10%), glycine (2.5 to 4%), alpha , alpha , diaminopimelic acid (5 to 8%), N-acetyl- glucosamine (5 to 10%) and muramic acid (5 to 10%).

GB7831772A
1977-08-04
1978-07-31
An immunostimulant, a process for preparing it, and compositions containing it

Withdrawn

GB2001995A
(en)

Applications Claiming Priority (1)

Application Number
Priority Date
Filing Date
Title

FR7724092A

FR2399437A1
(en)

1977-08-04
1977-08-04

NEW IMMUNOSTIMULANT SUBSTANCE, ITS PREPARATION PROCESS AND THE COMPOSITIONS CONTAINING IT

Publications (1)

Publication Number
Publication Date

GB2001995A
true

GB2001995A
(en)

1979-02-14

Family
ID=9194245
Family Applications (1)

Application Number
Title
Priority Date
Filing Date

GB7831772A
Withdrawn

GB2001995A
(en)

1977-08-04
1978-07-31
An immunostimulant, a process for preparing it, and compositions containing it

Country Status (6)

Country
Link

JP
(1)

JPS5427502A
(en)

BE
(1)

BE869058A
(en)

DE
(1)

DE2833799A1
(en)

FR
(1)

FR2399437A1
(en)

GB
(1)

GB2001995A
(en)

NL
(1)

NL7807938A
(en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party

Publication number
Priority date
Publication date
Assignee
Title

FR2466455A2
(en)

*

1979-10-05
1981-04-10
Anvar
Immunostimulant and adjuvant N-acyl-peptide derivs. – produced by N-acylation of peptides from streptomyces stimulosus water-soluble extract (BE 17.4.80)

GB2033906B
(en)

*

1978-10-19
1982-12-01
Anvar
Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them

JPS5766836U
(en)

*

1980-10-07
1982-04-21

1977

1977-08-04
FR
FR7724092A
patent/FR2399437A1/en
not_active
Withdrawn

1978

1978-07-17
BE
BE189329A
patent/BE869058A/en
unknown

1978-07-26
NL
NL787807938A
patent/NL7807938A/en
not_active
Application Discontinuation

1978-07-31
GB
GB7831772A
patent/GB2001995A/en
not_active
Withdrawn

1978-08-02
DE
DE19782833799
patent/DE2833799A1/en
active
Pending

1978-08-04
JP
JP9468578A
patent/JPS5427502A/en
active
Pending

Also Published As

Publication number
Publication date

JPS5427502A
(en)

1979-03-01

FR2399437A1
(en)

1979-03-02

BE869058A
(en)

1979-01-17

DE2833799A1
(en)

1979-02-15

NL7807938A
(en)

1979-02-06

Similar Documents

Publication
Publication Date
Title

SE8201351L
(en)

1982-03-04

SET TO MAKE LIPOSOM PREPARATIONS

ES2058317T3
(en)

1994-11-01

PROSTAGLANDIN-LIPIDO FORMULATIONS.

ES2033400T3
(en)

1993-03-16

PROCEDURE FOR PRODUCING STABLE PHARMACEUTICAL PREPARATIONS.

ES8506451A1
(en)

1985-07-16

Process for the preparation of lyophilized, adsorbed polyvalent vaccines

OA06421A
(en)

1981-09-30

Process for the preparation of N- (vinblastinoyl-23) derivatives of amino acids and peptides.

SE8304920D0
(en)

1983-09-13

NOVEL PHARMACOLOGICAL COMPOSITIONS BASED ON CISPLATINUM AND METHOD FOR OBTAINING SAME

FI885358A
(en)

1989-05-20

Process for producing an injectable melphalan composition

HUT44433A
(en)

1988-03-28

Process for preparing compositions comprising unsaturated fatty acids necessary for the synthesis of prostaglandines and hydroxy-fatty acids in biological systems

US4013788A
(en)

1977-03-22

Watersoluble extracts of corynebacteria, process for obtaining them and their use

ES522637A0
(en)

1984-12-01

PROCEDURE FOR THE PREPARATION OF NEW SUBSTANCES WS 6049.

GB2001995A
(en)

1979-02-14

An immunostimulant, a process for preparing it, and compositions containing it

CA2106854A1
(en)

1993-08-15

Extract of bacterial macromolecules, a process for its preparation and a pharmaceutical composition containing the same

GB2020665A
(en)

1979-11-21

Acyl-N-acetylmuramylpeptide- antigen conjugate

AU536582B2
(en)

1984-05-10

Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends

RU94040393A
(en)

1996-11-10

Synthetic peptides for vaccine against german measles

US4228068A
(en)

1980-10-14

Peptide complexes of DNA-containing organisms

EP0090660A3
(en)

1983-11-23

Neisseria gonorrhoeae vaccine

ES8800275A1
(en)

1987-11-01

POLYDISPERSED NATIVE PSEUDOMONAS-FLAGELLA (H)-ANTIGENS (FAg) AND METHODS FOR THEIR PREPARATION.

EP0283443A3
(en)

1990-01-24

Process for extracting membrane antigens having immunogenic properties from human neoplastic cells and products thereby obtained

Levenbook et al.

1986

Sensitization induced in guinea pigs with beta-propriolactone-treated serum albumin: experimental evidence for the cause of allergic reactions in humans receiving human diploid cell rabies vaccines

BE773689A
(en)

1972-04-10

NEW ESTERS OF PYRIDAZINOTHIONOPHOSPHORIC (PHOSPHONIC) ACIDS, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS INSECTICIDES AND ACARICIDES

Martyre et al.

1974

The in vivo Activity of Soluble Extracts Obtained from RC 19 Leukemia: Effect of the Method of Extraction

JPS5275580A
(en)

1977-06-24

Process for the preparation of feed

JPS5599072A
(en)

1980-07-28

Production of artificial antigen containing choline residue

SE8400934L
(en)

1984-08-23

PROCEDURE FOR THE PREPARATION OF LYOPHILIZED, ADSORPED, POLYVALENT VACCINES

Legal Events

Date
Code
Title
Description

1980-02-13
WAP
Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)

Download PDF in English

None